机译:展开的蛋白质反应:一种新的预后BRAF突变型结直肠癌的新疗法靶标
Queens Univ Belfast Sch Med Dent &
Biomed Sci Ctr Canc Res &
Cell Biol Drug Resistance Grp;
Queens Univ Belfast Sch Med Dent &
Biomed Sci Ctr Canc Res &
Cell Biol Drug Resistance Grp;
Queens Univ Belfast Sch Med Dent &
Biomed Sci Ctr Canc Res &
Cell Biol Drug Resistance Grp;
Queens Univ Belfast Sch Med Dent &
Biomed Sci Ctr Canc Res &
Cell Biol Drug Resistance Grp;
Queens Univ Belfast Sch Med Dent &
Biomed Sci Ctr Canc Res &
Cell Biol Drug Resistance Grp;
Queens Univ Belfast Sch Med Dent &
Biomed Sci Ctr Canc Res &
Cell Biol Drug Resistance Grp;
Queens Univ Belfast Sch Med Dent &
Biomed Sci Ctr Canc Res &
Cell Biol Drug Resistance Grp;
Almac Discovery Labs Ctr Precis Therapeut Belfast Antrim North Ireland;
Masarykova Univ Res Ctr Tox Cpds Environm Fac Sci Brno Czech Republic;
Sidra Med &
Res Ctr Div Biomed Informat Educ City North Campus Doha Qatar;
Univ Torino Dept Oncol Sch Med Turin Italy;
Queens Univ Belfast Sch Med Dent &
Biomed Sci Ctr Canc Res &
Cell Biol Drug Resistance Grp;
Queens Univ Belfast Sch Med Dent &
Biomed Sci Ctr Canc Res &
Cell Biol Drug Resistance Grp;
Queens Univ Belfast Sch Med Dent &
Biomed Sci Ctr Canc Res &
Cell Biol Drug Resistance Grp;
Queens Univ Belfast Sch Med Dent &
Biomed Sci Ctr Canc Res &
Cell Biol Drug Resistance Grp;
机译:展开的蛋白质反应:一种新的预后BRAF突变型结直肠癌的新疗法靶标
机译:MicroRNA-204通过靶向高迁移率族蛋白A2调节基于5-氟尿嘧啶的治疗对结直肠癌细胞的敏感性MicroRNA-204通过靶向高迁移率族蛋白A2调节对5-氟尿嘧啶基于治疗的结直肠癌细胞的敏感性204通过靶向高迁移率族蛋白A2来调节基于5-氟尿嘧啶的治疗对大肠癌细胞的敏感性
机译:靶向BRAF突变性结直肠癌的RAF激酶的小分子疗法的发展和策略
机译:展开蛋白质反应自噬作为抗癌治疗的有前途的可用毒性目标
机译:在不良预后的癌症中,Cadherin-11介导的肿瘤进展和侵袭:可行的治疗靶点。
机译:展开的蛋白反应:预后不良的BRAF突变型结直肠癌的新型治疗靶点
机译:癌胚抗原和碳水化合物抗原19-9在转移性结直肠癌中的预后作用:高CA 19-9水平的BRAF突变体子集和差